Acquired hemophilia in a 7-year-old girl successfully treated with recombinant FVIIA and steroids: A case report

Clin Case Rep. 2020 Dec 3;9(2):638-643. doi: 10.1002/ccr3.3588. eCollection 2021 Feb.

Abstract

Acquired hemophilia should be evaluated in pediatric patients with bleeding and isolated prolonged aPTT. Immunosuppressive treatment should be initiated even in minor bleedings. Bypassing agents like rFVIIa can be used in children with success.

Keywords: Acquired hemophilia A; factor VIII deficiency; pediatric population; recombinant factor VII activated.

Publication types

  • Case Reports